[Clinical features of XXXX : report of 12 cases].

@entity1 @entity981 @entity882 @entity384 @entity409 @entity551 @entity1778 @entity1017 @entity381 @entity5501 @entity382 @entity925
OBJECTIVE: To summarize the clinical features of @entity5501 ( @entity5501 ) and to improve the understanding of this disease. METHODS: A retrospective study was performed on the clinical data of 12 @entity1 with @entity5501 including clinical manifestations, laboratory results, imaging findings, treatment, and prognosis. RESULTS: Of the 12 cases, 8 were secondary to @entity981 , and 4 had undergone hematopoietic stem cell transplantation. Manifestations mainly included abdominal distention (4 cases), @entity382 with @entity925 (9 cases), @entity381 (6 cases), and weight increase (10 cases). Biochemical tests revealed varying degrees of @entity409 in all cases. In the coagulation function test, the activated partial thromboplastin time (APTT) was prolonged in 7 cases. Out of the 7 @entity1 who underwent serum D-dimer test, 4 showed elevated serum level of D-dimer. In routine blood tests, 4 cases showed @entity551 and neutrophils. In addition, varying degrees of @entity882 were observed in 9 cases. Eight @entity1 were subjected to color Doppler ultrasound examination, and diffuse @entity382 , inhomogeneous @entity409 , unclear or thinner hepatic veins, hydrothorax/ascites, or @entity381 was observed. @entity384 or hepatic cell infiltration was observed in 2 @entity1 who underwent liver biopsy. Treatments were basically symptomatic and supportive therapies, and the prognosis was good in all @entity1 . CONCLUSIONS: @entity5501 should be considered in @entity1 who present with @entity382 , sudden @entity1017 , @entity409 and @entity409 after they have received chemotherapy for @entity1778 and hematopoietic stem cell transplantation.
